News and Press Releases
PTC Therapeutics Announces FDA Acceptance for Filing of NDA for Sepiapterin for the Treatment of Pediatric and Adult Phenylketonuria Patients
1 October 2024 -- New Jersey, US -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the FDA has accepted for filing the New Drug Application (NDA) of sepiapterin for the treatment of...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: October 1, 2024
PTC Therapeutics Inc. 100 Corporate Court South Plainfield, NJ 07080-2449
CARVYKTI® ▼ (ciltacabtagene autoleucel; cilta-cel) is the first cell therapy to significantly extend overall survival versus standard therapies for patients with multiple myeloma as early as second line
45 percent reduction in risk of death achieved with cilta-cel versus standard therapies after threeyear follow-up in landmark CARTITUDE-4 study Data featured in a late-breaking oral presentation at the 2024...
Category:
Posted: October 1, 2024
Janssen-Cilag Limited 50-100 Holmers Farm Way High Wycombe Buckinghamshire HP12 4EG
AzurBio Pharma Launches to Fast-Track European Market Entry for Biopharma Companies with Breakthrough Treatments
1 October 2024 -- Paris, France -- AzurBio Pharma, specializing in bringing innovative pharmaceutical products to European markets and focusing on rare and serious diseases with unmet medical needs, is...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 1, 2024
Sarepta Therapeutics Announces Recipients of LGMD Grant Awards for 2024; Program Supports Early Genetic Testing and Awareness
Recipients awarded a total of more than $100,000 in grants Funding will support education and activities to shorten diagnostic journey. 30 September 2024 -- Massachusetts, US -- Sarepta Therapeutics, Inc, the...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: September 30, 2024
Hill House, 1 Little New Street London, EC4A 3TR United Kingdom
Thermo Fisher Scientific Launches International CorEvitas Clinical Registry in Adolescent Atopic Dermatitis, a Chronic Skin Condition
30 September 2024 -- Massachusetts, US -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the international CorEvitas Adolescent Atopic Dermatitis (AD) Registry,...
Category: Clinical Trials, Drug Delivery, Pharmaceutical
Posted: September 30, 2024
PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
Milestone triggers payments to PureTech totaling $29 million under agreements with Royalty Pharma and PureTech’s Founded Entity, Karuna Therapeutics, which was acquired by Bristol Myers Squibb in March 2024, and...
Category: Other, Pharmaceutical
Posted: September 27, 2024
CluePoints Launches Medical & Safety Review (MSR) Software to Revolutionize Clinical Data Review
CluePoints furthers its commitment to delivering innovative solutions that enhance clinical trial efficiency with this latest addition to its enterprise software platform 27 September 2024 -- Pennsylvania, US -- CluePoints...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: September 27, 2024
IFF Pharma Solutions Brings New Innovations and Excipient Excellence to CPHI 2024
26 September 2024 – New York, NY, US – IFF (NYSE:IFF) Pharma Solutions is proud to announce its more than 75-year legacy as an excipient manufacturer with new product launches...
Category: Manufacturing and Packing
Posted: September 26, 2024
Phesi launches Investigator Site Profile solution, enabling sponsors to eliminate non-active, non-enrolling trial sites
AI-powered analysis of 120m patient profiles and 600,000 global investigator records delivers deep visibility into investigator site expertise, experience and clinical relevance 26 September 2024 -- Massachusetts, US -- Phesi,...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 26, 2024
At MD&M Minneapolis, TekniPlex Healthcare to Highlight Concept-to-Commercialization Capabilities for Class III Implantable Devices and Delivery Systems
Comprehensive services punctuated by precision, tight-tolerance metalworking expertise and injection molding solutions; company also will display range of medical tubing such as catheter-based systems, as well as select medical device...
Category: Logistics, Manufacturing and Packing
Posted: September 26, 2024
Industrielaan 37 B-9320 Erembodegem Belgium Tel: +32 (0)53 650711 VAT 0425.537.515
PCI Pharma Services Invests Over $365 Million in EU, US Facilities for Clinical and Commercial Supply of Advanced Drug Delivery and Drug-Device Combination Products
Highlights include investment in Philadelphia biotech facility, acquisition of a new pharma device assembly and packaging facility near Dublin, Ireland, and a new Center of Excellence for advanced drug delivery...
Category: Drug Delivery
Posted: September 25, 2024
Medidata Extends Its Commitment to the Patient Experience with the Launch of Patient Payments
New solution accelerates payments to patients participating in a clinical trial, improving experience and access 25 September 2024 -- New York, US -- Medidata, a Dassault Systèmes brand and leading...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 25, 2024
Just – Evotec Biologics opens cutting-edge biologics facility – J.POD® Toulouse, France (EU)
J.POD® Toulouse, France (EU) brings disruptive, scalable continuous biologics manufacturing technology to the region Just – Evotec Biologics’ J.POD® technology offers a paradigm shift in biomanufacturing with cost-effective and flexible clinical and...
Category: BioManufacturing
Posted: September 25, 2024
Just – Evotec Biologics, Inc. 401 Terry Avenue North Seattle, WA 98109, US
Steritas’ Pediatric Glucocorticoid Toxicity Index applied by Alder Hey Children’s NHS Foundation Trust and Liverpool Clinical Trials Centre in clinical trial to assess steroid-toxicity in children with juvenile idiopathic arthritis
Study will allow researchers to assess the outcomes of intravenous and oral glucocorticoid protocols in children 24 September 2024 -- Massachusetts, US -- Steritas LLC., a company dedicated to enhancing...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: September 24, 2024
Duke Street Bio Granted Approval by European Medicines Agency to Launch Next-Generation PARP1-Selective Inhibitor Trial
24 September 2024 -- London, UK -- Duke Street Bio Ltd, a precision medicine biotech developing next generation small molecule cancer therapies, is pleased to announce that the European Medicines...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 24, 2024
